96 related articles for article (PubMed ID: 27632554)
1. The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.
Simonsson M; Björner S; Markkula A; Nodin B; Jirström K; Rose C; Borgquist S; Ingvar C; Jernström H
Int J Cancer; 2017 Jan; 140(1):163-175. PubMed ID: 27632554
[TBL] [Abstract][Full Text] [Related]
2. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.
Elebro K; Butt S; Dorkhan M; Jernström H; Borgquist S
Cancer Causes Control; 2014 Aug; 25(8):945-57. PubMed ID: 24825327
[TBL] [Abstract][Full Text] [Related]
3. History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
Huzell L; Persson M; Simonsson M; Markkula A; Ingvar C; Rose C; Jernström H
Breast Cancer Res Treat; 2015 Jan; 149(2):505-15. PubMed ID: 25556354
[TBL] [Abstract][Full Text] [Related]
4. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
[TBL] [Abstract][Full Text] [Related]
5. Survival in breast cancer and age at start of oral contraceptive usage.
Ranstam J; Olsson H; Garne JP; Aspegren K; Janzon L
Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
[TBL] [Abstract][Full Text] [Related]
6. The importance of COX-2 expression as prognostic factor in early breast cancer.
Kargi A; Uysal M; Bozcuk H; Coskun HS; Savas B; Ozdogan M
J BUON; 2013; 18(3):579-84. PubMed ID: 24065467
[TBL] [Abstract][Full Text] [Related]
7. Early oral contraceptive use as a prognostic factor in breast cancer.
Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
[TBL] [Abstract][Full Text] [Related]
8. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
9. Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort.
Elebro K; Borgquist S; Simonsson M; Markkula A; Jirström K; Ingvar C; Rose C; Jernström H
Clin Cancer Res; 2015 Aug; 21(16):3640-50. PubMed ID: 25904752
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
11. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
[TBL] [Abstract][Full Text] [Related]
14. Impact of cyclooxygenase-2 in breast cancer.
Hoellen F; Kelling K; Dittmer C; Diedrich K; Friedrich M; Thill M
Anticancer Res; 2011 Dec; 31(12):4359-67. PubMed ID: 22199301
[TBL] [Abstract][Full Text] [Related]
15. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
16. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome.
Nassar A; Radhakrishnan A; Cabrero IA; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):255-9. PubMed ID: 17721268
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group.
Sauerbrei W; Blettner M; Schmoor C; Bojar H; Schumacher M
Eur J Cancer; 1998 Aug; 34(9):1348-51. PubMed ID: 9849415
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
